Truist Financial’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Truist Financial’s Portfolio KNSA Stock Details KNSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.3M	Buy	+51,671	New	+$2.68M	﹤0.01%	1125

Other funds holding KNSA

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

LTAS

Linden Thomas Advisory Services Charlotte, North Carolina $1.24B AUM 47.37% 1-Year Est. Return

FEG

Financial Enhancement Group Anderson, Indiana $839M AUM 18.63% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

TFA

Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

JWS

Juncture Wealth Strategies Scottsdale, Arizona $384M AUM 27.62% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

AAM

AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return

PAS

Park Avenue Securities New York $16B AUM 26.77% 1-Year Est. Return

Truist Financial's KNSA Position: Q2 2026 in Review

Truist Financial opened a new position in Kiniksa Pharmaceuticals (KNSA) in Q2 2026: 51,671 shares worth $3.3M. The stake represents ﹤0.01% of the portfolio and ranks #1125 among its holdings.

43 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

Truist Financial held 51,671 shares of Kiniksa Pharmaceuticals worth $3.3M as of Q2 2026.
Kiniksa Pharmaceuticals was a new Truist Financial position in Q2 2026.
Kiniksa Pharmaceuticals made up ﹤0.01% of Truist Financial's portfolio in Q2 2026, its #1125 holding.
43 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.